MediciNoava Shares Sell Off Sharply From Premarket, Down ~18.5%; Co. Reported MN-001 Study Showed Significant Serum Triglyceride Reduction In Liver Disease Patients, Co. Will Discontinue Enrollment To Accelerate Further Development
Paul Quintaro